File: /home/govancoz/mail/.spam/new/1694344084.M271960P372959.zacp120.ve.host,S=9427,W=9595
Return-Path: <rma@keychron.in>
Delivered-To: govancoz+spam@zacp120.ve.host
Received: from zacp120.ve.host
by zacp120.ve.host with LMTP
id AA7xD5Sj/WTfsAUAvcbEzQ
(envelope-from <rma@keychron.in>)
for <govancoz+spam@zacp120.ve.host>; Sun, 10 Sep 2023 13:08:04 +0200
Return-path: <rma@keychron.in>
Envelope-to: candice@govan.co.za
Delivery-date: Sun, 10 Sep 2023 11:08:04 +0000
Received: from [159.89.172.2] (port=40123 helo=zealous-sutherland.159-89-172-2.plesk.page)
by zacp120.ve.host with esmtps (TLS1.3) tls TLS_AES_256_GCM_SHA384
(Exim 4.96)
(envelope-from <rma@keychron.in>)
id 1qfIIL-001ZkP-2c
for candice@govan.co.za;
Sun, 10 Sep 2023 11:08:04 +0000
Received: from [169.254.129.240] (ns1001864.ip-92-204-128.us [92.204.128.76])
by zealous-sutherland.159-89-172-2.plesk.page (Postfix) with ESMTPA id AF33CA8366;
Sat, 9 Sep 2023 18:27:26 +0000 (UTC)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=keychron.in;
s=default; t=1694284060;
bh=NNer3XsQNyjWMLdYYHON/DGpgN8TE4SSdxxGgS7VgBA=; h=Subject:To:From;
b=cDSq/DGFR3EXeSEldd1G6Uh9lifvpL9i0kVkeQYPRUISPTWtlv13xeFBgnUONBGpq
QZdxXd6QUMGLdD0UDBHBh+nq0LtYi3/mRF/YNXgibS55hwSZYoLaMHaBepmo4elJ41
haggz7F9vJ7QsDSZvqnGHvOAmbhgV1KAux24dFMk=
Authentication-Results: zealous-sutherland.159-89-172-2.plesk.page;
spf=pass (sender IP is 92.204.128.76) smtp.mailfrom=rma@keychron.in smtp.helo=[169.254.129.240]
Received-SPF: pass (zealous-sutherland.159-89-172-2.plesk.page: connection is authenticated)
Content-Type: multipart/alternative; boundary="===============0796425715=="
MIME-Version: 1.0
To: Recipients <rma@keychron.in>
From: "Dr. Yasunobu Otsuga" <rma@keychron.in>
Date: Sat, 09 Sep 2023 11:27:12 -0700
Reply-To: yasunobuotsuga1@gmail.com
X-Spam-Status: Yes, score=12.5
X-Spam-Score: 125
X-Spam-Bar: ++++++++++++
X-Spam-Report: Spam detection software, running on the system "zacp120.ve.host",
has identified this incoming email as possible spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Hello Daito Pharma Co., Ltd. is a Japan-based manufacturing
pharmaceutical company engaged in the pharmaceutical ingredients and formulation
business . Are you interested in working with us to be our [...]
Content analysis details: (12.5 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
1.3 RCVD_IN_VALIDITY_RPBL RBL: Relay in Validity RPBL,
https://senderscore.org/blocklistlookup/
[159.89.172.2 listed in bl.score.senderscore.com]
1.5 SPF_SOFTFAIL SPF: sender does not match SPF record (softfail)
0.5 SUBJ_ALL_CAPS Subject is all capitals
0.2 FREEMAIL_REPLYTO_END_DIGIT Reply-To freemail username ends in
digit
[yasunobuotsuga1[at]gmail.com]
2.7 RCVD_IN_PSBL RBL: Received via a relay in PSBL
[159.89.172.2 listed in psbl.surriel.com]
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
2.0 PYZOR_CHECK Listed in Pyzor
(https://pyzor.readthedocs.io/en/latest/)
2.0 RDNS_NONE Delivered to internal network by a host with no rDNS
0.0 FSL_BULK_SIG Bulk signature with no Unsubscribe
2.5 FREEMAIL_FORGED_REPLYTO Freemail in Reply-To, but not From
X-Spam-Flag: YES
Subject: ***SPAM*** PROPOSED PARTNERSHIP.
You will not see this in a MIME-aware mail reader.
--===============0796425715==
Content-Type: text/plain; charset="utf-8"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
Hello =
Daito Pharma Co., Ltd. is a Japan-based manufacturing pharmaceutical comp=
any engaged in the pharmaceutical ingredients and formulation business . Ar=
e you interested in working with us to be our company representative in you=
r country, The Republic of South Africa, for a period of five years contrac=
t? Please Kindly let us know if you are interested while I direct you to m=
y working company email address =
Apologies for using my personal email address for these proposals. However=
, The reason was to get an immediate notification from you once you respond=
ed. =
Best regards,
Dr. Yasunobu Otsuga President & CEO Daito Pharmaceutical Co., Ltd. 326 Yoka=
machi, Toyama City, Toyama Prefecture 939-8567
--===============0796425715==
Content-Type: text/html; charset="utf-8"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Dutf-8"/></head><BODY><DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial,=
Helvetica, sans-serif; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSF=
ORM: none; FONT-WEIGHT: 400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPH=
ANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-l=
igatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px=
; text-decoration-thickness: initial; text-decoration-style: initial; text-=
decoration-color: initial">Hello</DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l"><BR></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">Daito Pharma Co., Ltd. is a Japan-based manufacturing pharmaceutic=
al company engaged in the pharmaceutical ingredients and formulation busine=
ss . Are you interested in working with us to be our company representative=
in your country, The Republic of South Africa, for a period of five years =
contract? Please Kindly let us know if you are interested while I dir=
ect you to my working company email address</DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">
<DIV><BR></DIV>
<DIV>Apologies for using my personal email address for these proposals. How=
ever, The reason was to get an immediate notification from you once you res=
ponded.</DIV></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l"><BR></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">
<DIV><SPAN style=3D"FONT-SIZE: 11pt; FONT-FAMILY: Gulim, =EA=B5=B4=EB=A6=BC=
, sans-serif; COLOR: rgb(0,0,0)">Best regards,</SPAN><BR style=3D"FON=
T-SIZE: 14px; FONT-FAMILY: Gulim, =EA=B5=B4=EB=A6=BC, sans-serif; COLOR: rg=
b(0,0,0)"><SPAN style=3D"FONT-SIZE: 11pt"><SPAN style=3D"FONT-FAMILY: Gulim=
, =EA=B5=B4=EB=A6=BC, sans-serif; COLOR: rgb(0,0,0)">Dr. </SPAN></SPAN=
>Yasunobu Otsuga</DIV>
<DIV><SPAN style=3D"FONT-SIZE: 11pt; FONT-FAMILY: Gulim, =EA=B5=B4=EB=A6=BC=
, sans-serif; COLOR: rgb(0,0,0)">President & CEO</SPAN></DIV>
<DIV>Daito Pharmaceutical Co., Ltd.</DIV>
<DIV>326 Yokamachi, Toyama City, Toyama Prefecture 939-8567</DIV></DIV></BO=
DY></HTML>
--===============0796425715==--